[CAS NO. 27214-00-2]??Monocalcium glycerophosphate
PRODUCTS SPECIFICATIONS [27214-00-2]
DESCRIPTION [27214-00-2]
Overview
| MDL | MFCD00042643 |
|---|---|
| Molecular Weight | 210.14 |
| Molecular Formula | C3H7CaO6P |
| SMILES | O=P([O-])([O-])OCC(O)CO.[Ca+2] |
Summary
Calcium glycerophosphate is an inhibitor of intestinal alkaline phosphatase F3 . Calcium glycerophosphate is a source of calcium and phosphorus in total parenteral nutrition solutions [1] [2] .
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT01264588 | AkPharma Inc.|Rothman Institute Orthopaedics|Texas Tech University Health Sciences Center|Cyberderm Inc.|Bacharach Institute for Rehabilitation, Pomona, NJ |
Wound Healing|Scarring
|
April 2008 | Not Applicable |
| NCT00875212 | Federal University of Paraíba|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Coordination for the Improvement of Higher Education Personnel |
Dental Caries
|
January 2006 | Phase 1 |
| NCT01647633 | Drexel University|AkPharma Inc. |
Allergic Rhinitis
|
May 2012 | Phase 1|Phase 2 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble or slightly soluble)
H 2 O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)
References
- [1] Datta P, et al. Calcium glycerophosphate preserves transepithelial integrity in the Caco-2 model of intestinal transport. World J Gastroenterol. 2015;21(30):9055-9066.
- [2] Draper HH, et al. Calcium glycerophosphate as a source of calcium and phosphorus in total parenteral nutrition solutions. JPEN J Parenter Enteral Nutr. 1991;15(2):176-180.
Synonyms